TEAM HEALTH HOLDINGS INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Operating activities
Net earnings
Adjustments to reconcile net earnings:
Depreciation
Amortization
Amortization of deferred financing costs
Equity based compensation expense
Provision for uncollectibles
Impairment of intangibles
Deferred income taxes
Non-cash loss on refinancing of debt
Loss on assets held for sale
Loss (gain) on disposal or sale of equipment
Equity in joint venture income
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
Prepaids and other assets
Income tax accounts
Accounts payable
Accrued compensation and physician payable
Contingent purchase liabilities
Other accrued liabilities
Professional liability reserves
Professional liability reserves

Net cash provided by operating activities
Investing activities
Purchases of property and equipment
Sale of property and equipment
Cash paid for acquisitions, net of cash acquired
Purchases of investments at insurance subsidiary
Proceeds from investments at insurance subsidiary
Net proceeds from disposition of assets held for sale
Proceeds from the sale of investments
Purchases of investments at insurance subsidiaries
Subsidiaries
Total purchases of investments at insurance subsidiaries
Proceeds from investments at insurance subsidiaries
Subsidiaries
Total proceeds from investments at insurance subsidiaries
Other investing activities
Net cash used in investing activities

Financing activities
Payments on notes payable
Proceeds on notes payable
Payments on 11.25% senior subordinated notes
Proceeds from sale of common stock
Proceeds on 7.25% Senior Notes
Payments on IPC assumed notes payable
Proceeds from revolving credit facility
Payments of debt issuance costs
Payments related to contingent purchase obligations
Contribution from noncontrolling interests
Distributions to noncontrolling interests
Stock issuance costs
Proceeds from the issuance of common stock under stock purchase plans
Proceeds from exercise of stock options
Tax benefit from exercise of stock options
Net cash provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental cash flow information:
Interest paid
Taxes paid
Fair value of equity awards, IPC Acquisition

Comments